Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.0 | $2,029.4K | $2,808.9K | $4,912.5K | $6,084.2K | $8,332.9K | $17.1M | $49.5M | $29.0M | $87.4M | $51.2M | $497.3M | $410.7M | $1,226.3M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, argenx SE's last 12-month Revenue is $2,258.9M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, argenx SE's Revenue growth was 127.3%. The average annual Revenue growth rates for argenx SE have been 126.5% over the past three years, 102.0% over the past five years.
Over the last year, argenx SE's Revenue growth was 127.3%, which is higher than industry growth of 3.1%. It indicates that argenx SE's Revenue growth is Good.